LIST OF TABLES
TABLE 1 AGEING WORLD POPULATION
TABLE 2 POSTOPERATIVE PULMONARY EMBOLISM OR DEEP VEIN THROMBOSIS IN HIP AND KNEE SURGERIES, 2015
TABLE 3 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 4 ASIA-PACIFIC DEEP VEIN THROMBOSIS (DVT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 ASIA-PACIFIC PULMONARY EMBOLISM (PE) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 ASIA-PACIFIC ARTERIAL THROMBOEMBOLISM (AT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 ASIA-PACIFIC STROKE IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 ASIA-PACIFIC OTHERS IN ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 10 ASIA-PACIFIC NOVEL ORAL ANTICOAGUALTANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 ASIA-PACIFIC NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 12 ASIA-PACIFIC HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 ASIA-PACIFIC HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 14 ASIA-PACIFIC VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 ASIA-PACIFIC VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 16 ASIA-PACIFIC OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 18 ASIA-PACIFIC BIVALIRUDIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 ASIA-PACIFIC DABIGATRAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 ASIA-PACIFIC EDOXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 ASIA-PACIFIC BETRIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 ASIA-PACIFIC RIVAROXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 ASIA-PACIFIC APIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 ASIA-PACIFIC ENOXAPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 ASIA-PACIFIC DALTEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 ASIA-PACIFIC OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 27 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION , 2017-2026 (USD MILLION)
TABLE 28 ASIA-PACIFIC ORAL IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 ASIA-PACIFIC INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 ASIA-PACIFIC INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 31 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 32 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 34 ASIA-PACIFIC ONCOLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 ASIA-PACIFIC RESPIRATORY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 ASIA-PACIFIC NEPHROLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 37 ASIA-PACIFIC CNS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 ASIA-PACIFIC OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 40 ASIA-PACIFIC PRE-SURGICAL PROCEDURES IN ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 41 ASIA-PACIFIC POST-SURGICAL PROCEDURES IN ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 42 ASIA-PACIFIC KIDNEY DIALYSIS IN ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 43 ASIA-PACIFIC HEART VALVE REPLACEMENT IN ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 44 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 45 ASIA-PACIFIC GENERICS IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 46 ASIA-PACIFIC BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 47 ASIA-PACIFIC BRANDED IN ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 48 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 49 ASIA-PACIFIC HOSPITALS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 50 ASIA-PACIFIC CLINICS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 51 ASIA-PACIFIC HOMECARE IN ANTICOAGULATION THERAPY MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 52 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 53 ASIA-PACIFIC OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 54 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 55 ASIA-PACIFIC HOSPITAL PHARMACY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 56 RETAIL PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 57 ASIA-PACIFIC ONLINE PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 58 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 59 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 60 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 61 ASIA-PACIFIC NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 62 ASIA-PACIFIC HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 63 ASIA-PACIFIC VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 64 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 65 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 66 ASIA-PACIFIC INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 67 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 68 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 69 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 70 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 71 ASIA-PACIFIC BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION))
TABLE 72 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 74 JAPAN ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 75 JAPAN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 76 JAPAN NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 77 JAPAN HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 78 JAPAN VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 79 JAPAN ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 80 JAPAN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 81 JAPAN INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 82 JAPAN ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 83 JAPAN CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 84 JAPAN ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 85 JAPAN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 86 JAPAN BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 87 JAPAN ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 88 JAPAN ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 89 CHINA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 90 CHINA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 91 CHINA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 92 CHINA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 93 CHINA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 94 CHINA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 95 CHINA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 96 CHINA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 97 CHINA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 98 CHINA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 99 CHINA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 100 CHINA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 101 CHINA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 102 CHINA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 103 CHINA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 104 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 105 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 106 SOUTH KOREA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 107 SOUTH KOREA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 108 SOUTH KOREA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 109 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 110 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 111 SOUTH KOREA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 112 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 113 SOUTH KOREA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 114 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 115 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 116 SOUTH KOREA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 117 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 118 SOUTH KOREA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 119 INDIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 120 INDIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 121 INDIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 122 INDIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 123 INDIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 124 INDIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 125 INDIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 126 INDIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 127 INDIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 128 INDIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 129 INDIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 130 INDIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 131 INDIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 132 INDIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 133 INDIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 134 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 135 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 136 AUSTRALIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 137 AUSTRALIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 138 AUSTRALIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 139 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 140 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 141 AUSTRALIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 142 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 143 AUSTRALIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 144 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 145 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 146 AUSTRALIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 147 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 148 AUSTRALIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 149 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 150 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 151 SINGAPORE NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 152 SINGAPORE HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 153 SINGAPORE VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 154 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 155 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 156 SINGAPORE INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 157 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 158 SINGAPORE CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 159 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 160 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 161 SINGAPORE BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 162 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 163 SINGAPORE ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 164 THAILAND ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 165 THAILAND ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 166 THAILAND NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 167 THAILAND HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 168 THAILAND VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 169 THAILAND ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 170 THAILAND ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 171 THAILAND INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 172 THAILAND ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 173 THAILAND CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 174 THAILAND ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 175 THAILAND ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 176 THAILAND BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 177 THAILAND ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 178 THAILAND ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 179 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 180 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 181 MALAYSIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 182 MALAYSIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 183 MALAYSIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 184 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 185 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 186 MALAYSIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 187 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 188 MALAYSIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 189 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 190 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 191 MALAYSIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 192 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 193 MALAYSIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 194 INDONESIA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 195 INDONESIA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 196 INDONESIA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 197 INDONESIA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 198 INDONESIA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 199 INDONESIA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 200 INDONESIA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 201 INDONESIA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 202 INDONESIA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 203 INDONESIA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 204 INDONESIA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 205 INDONESIA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 206 INDONESIA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 207 INDONESIA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 208 INDONESIA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 209 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 210 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 211 PHILIPPINES NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 212 PHILIPPINES HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 213 PHILIPPINES VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 214 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 215 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 216 PHILIPPINES INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 217 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 218 PHILIPPINES CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 219 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 220 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 221 PHILIPPINES BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 222 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 223 PHILIPPINES ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 224 REST OF ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)

LIST OF FIGURE

LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET
FIGURE 2 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: DATA VALIDATION MODEL
FIGURE 3 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: ASIA-PACIFIC VS REGIONAL ANALYSIS
FIGURE 5 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET
FIGURE 10 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF VENOUS THROMBOEMBOLISM AND PULMONARY EMBOLISM AND GROWING NUMBER OF SURGERIES ARE EXPECTED TO DRIVE THE ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 12 DEEP VEIN THROMBOSIS(DVT) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET IN 2019 & 2026
FIGURE 13 ASIA-PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 14 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY TREATMENT, 2018
FIGURE 15 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY THERAPEUTIC CLASS, 2018
FIGURE 16 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY DRUG TYPE, 2018
FIGURE 17 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY ROUTE OF ADMINISTRATION, 2018
FIGURE 18 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY THERAPEUTIC AREA, 2018
FIGURE 19 ASIA-PACIFIC ANTICOAGULATION THERAPY TREATMENT MARKET: BY PROCEDURE, 2018
FIGURE 20 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY TYPE, 2018
FIGURE 21 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY END USER, 2018
FIGURE 22 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2018
FIGURE 23 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: SNAPSHOT (2018)
FIGURE 24 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2018)
FIGURE 25 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2019)
FIGURE 26 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2018 & 2026)
FIGURE 27 ASIA-PACIFIC ANTICOAGULATION THERAPY MARKET: BY TREATMENT (2019-2026)
FIGURE 28 ASIA-PACIFIC ANTICOAGULATION THERPAY MARKET: COMPANY SHARE 2018 (%)